Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,008 DKK | -1.08% | -2.43% | -6.82% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.82% | 18.79B | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B | |
-21.14% | 8.56B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab, BioNTech Expand Cancer Therapy Collaboration